000			01356 a2200373 4500
005			20250514080800.0
264		0	_c20031020
008			200310s 0 0 eng d
022			_a0954-6820
024	7		_a10.1046/j.1365-2796.2003.01226.x _2doi
040			_aNLM _beng _cNLM
100	1		_aKoopman, M M W
245	0	0	_aShort- and long-acting synthetic pentasaccharides. _h[electronic resource]
260			_bJournal of internal medicine _cOct 2003
300			_a335-42 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAcute Disease
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aBlood Coagulation _xdrug effects
650	0	4	_aCoronary Disease _xprevention & control
650	0	4	_aFactor Xa Inhibitors
650	0	4	_aFibrinolytic Agents _xtherapeutic use
650	0	4	_aFondaparinux
650	0	4	_aHemorrhage _xdrug therapy
650	0	4	_aHumans
650	0	4	_aOligosaccharides _xtherapeutic use
650	0	4	_aPolysaccharides _xtherapeutic use
650	0	4	_aThromboembolism _xdrug therapy
650	0	4	_aThrombosis _xdrug therapy
650	0	4	_aVenous Thrombosis _xprevention & control
700	1		_aBüller, H R
773	0		_tJournal of internal medicine _gvol. 254 _gno. 4 _gp. 335-42
856	4	0	_uhttps://doi.org/10.1046/j.1365-2796.2003.01226.x _zAvailable from publisher's website
999			_c12742017 _d12742017